Related Experiment Video
Updated: Oct 13, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Benzothiazoloquinolines as protease-activated receptor 4 (PAR4) antagonists with excellent rat pharmacokinetic
Jeremy M Richter1, J Alex Bates1, Xiaojun Zhang1
1Bristol-Myers Squibb, Route 206 & Province Line Road, Lawrenceville, NJ, 08543, USA.
Abstract:
A novel series of quinoline-based PAR4 antagonists with single digit nanomolar potency has been discovered through iterative structure-activity relationship optimization. This series of quinoline antagonists demonstrates excellent rat pharmacokinetic properties with favorable oral exposure and Cmax.
Related Concept Videos
Anthelminthic Agents
Dipeptidyl Peptidase 4 Inhibitors
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Inhibitors of Bacterial DNA Synthesis
